PDSB
Price
$1.11
Change
-$0.01 (-0.89%)
Updated
Aug 8 closing price
Capitalization
50.74M
2 days until earnings call
PHAT
Price
$9.40
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Capitalization
690.99M
87 days until earnings call
Interact to see
Advertisement

PDSB vs PHAT

Header iconPDSB vs PHAT Comparison
Open Charts PDSB vs PHATBanner chart's image
PDS Biotechnology
Price$1.11
Change-$0.01 (-0.89%)
Volume$248.33K
Capitalization50.74M
Phathom Pharmaceuticals
Price$9.40
Change-$0.00 (-0.00%)
Volume$804
Capitalization690.99M
PDSB vs PHAT Comparison Chart in %
Loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDSB vs. PHAT commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and PHAT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (PDSB: $1.11 vs. PHAT: $9.40)
Brand notoriety: PDSB and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 52% vs. PHAT: 0%
Market capitalization -- PDSB: $50.74M vs. PHAT: $690.99M
PDSB [@Biotechnology] is valued at $50.74M. PHAT’s [@Biotechnology] market capitalization is $690.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 1 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 1 green, 4 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, both PDSB and PHAT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 3 TA indicator(s) are bullish while PHAT’s TA Score has 3 bullish TA indicator(s).

  • PDSB’s TA Score: 3 bullish, 2 bearish.
  • PHAT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than PHAT.

Price Growth

PDSB (@Biotechnology) experienced а +2.30% price change this week, while PHAT (@Biotechnology) price change was +12.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.49%. For the same industry, the average monthly price growth was +31.98%, and the average quarterly price growth was +19.31%.

Reported Earning Dates

PDSB is expected to report earnings on Aug 13, 2025.

PHAT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+22.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($691M) has a higher market cap than PDSB($50.7M). PHAT YTD gains are higher at: 15.764 vs. PDSB (-31.902). PDSB has higher annual earnings (EBITDA): -33.08M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. PDSB (40M). PDSB has less debt than PHAT: PDSB (19M) vs PHAT (204M). PHAT has higher revenues than PDSB: PHAT (81.9M) vs PDSB (0).
PDSBPHATPDSB / PHAT
Capitalization50.7M691M7%
EBITDA-33.08M-272.12M12%
Gain YTD-31.90215.764-202%
P/E RatioN/AN/A-
Revenue081.9M-
Total Cash40M212M19%
Total Debt19M204M9%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBPHAT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPGSX12.420.13
+1.06%
MassMutual Disciplined Gr R5
CLPCX12.910.10
+0.78%
Catalyst Nasdaq-100 Hedged Equity C
MIRTX34.440.26
+0.76%
MFS Massachusetts Investors Tr R2
MACPX27.050.09
+0.33%
BlackRock Balanced Institutional
WFLLX20.14N/A
N/A
Allspring Large Cap Core Admin

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with ARCT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-0.89%
ARCT - PDSB
49%
Loosely correlated
-0.58%
IDYA - PDSB
45%
Loosely correlated
+3.08%
RXRX - PDSB
45%
Loosely correlated
-0.92%
DYN - PDSB
45%
Loosely correlated
N/A
SYRE - PDSB
43%
Loosely correlated
N/A
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with RGNX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
N/A
RGNX - PHAT
36%
Loosely correlated
-0.63%
URGN - PHAT
34%
Loosely correlated
-4.55%
PDSB - PHAT
34%
Loosely correlated
-0.89%
ACIU - PHAT
33%
Loosely correlated
+2.88%
CCCC - PHAT
32%
Poorly correlated
-3.10%
More